Scientific evidence of AKK probiotics published in the authoritative journal Nature - Part Two

Acetobacterium muciniphila (AKK bacteria, abbreviated as AKK) is an important intestinal probiotic. It has published several highly influential articles in the series of Cell (including Cell, Cell Reports, Cell Host & Microbe, etc.). These studies mainly focus on the mechanisms of the relationship between AKK bacteria and host metabolism, immune response, and diseases. Here are the main articles of AKK bacteria in the Cell series and their core scientific conclusions (as of April 6, 2025, based on existing literature and research trends)

1. Nature (2022) – “Akkermansia muciniphila phospholipid induces homeostatic immune responses”

·Publishing Date: July 27, 202

·Main conclusion:

The study identified a lipid component in the cell membrane of the AKK bacteria - diacylphosphatidylethanolamine (a15:0-i15:0 PE), which has immunomodulatory activity and can reproduce the immunomodulatory effect of the AKK bacteria in vitro.

This lipid activates the immune response through an atypical TLR2-TLR1 heterodimer signaling pathway, demonstrating a strict structure-activity relationship.

The conclusion indicates that this lipid may be one of the molecular bases for the AKK bacteria to improve the host's metabolism and immune homeostasis (such as its role in obesity and cancer immunotherapy), providing a potential path for the development of targeted drugs.

2. Nature Microbiology (2021) – “Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice”

·Publishing Date: April 5, 2021

·Main conclusion:

The AKK bacteria secrete an 84 kDa protein (named P9), which can induce the secretion of glucagon-like peptide-1 (GLP-1) by intestinal endocrine cells and promote heat production in brown adipose tissue in mice fed with a high-fat diet.

P9: By interacting with the intercellular adhesion molecule 2 (ICAM-2) of the host cell, it activates the Ca²⁺-dependent pathway, thereby improving glucose homeostasis and metabolic diseases.

Studies have shown that the use of purified P9 alone is sufficient to simulate some of the metabolic benefits of AKK bacteria, suggesting that it could be a potential candidate for the treatment of metabolic syndrome.

3. Nature Microbiology (2023) – “Mutagenesis reveals how Akkermansia muciniphila degrades mucin and colonizes the gut”

·Publishing Date: June 21, 2023

·Main conclusion:

Through mutation analysis, the study identified the key genes that are essential for the AKK bacteria in the degradation of mucin and the establishment of intestinal colonization.

The mucin metabolism ability of AKK bacteria enables them to compete for survival within the intestinal microbiota and to affect the transcriptional downregulation of host intestinal cholesterol biosynthesis genes.

The study highlights that the AKK bacteria maintain the intestinal ecological balance through mucin metabolism and their impact on the host's metabolism.

4. Nature Reviews Gastroenterology & Hepatology (2022) – “Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms”

·Publishing Date: May 30, 202

·Main conclusion:

This review summarizes the history of the discovery of AKK bacteria and its association with various diseases (such as obesity, diabetes, hepatic steatosis, inflammation, and cancer immunotherapy responses).

Moving from correlational evidence to causal evidence, studies have shown that the AKK bacteria improve health by enhancing the intestinal barrier, regulating immune and metabolic pathways.

Emphasizing the potential of AKK bacteria as the next generation of probiotics, and comparing it with other candidate probiotics.

5. Nature Reviews Microbiology (2024) – “Akkermansia muciniphila: biology, microbial ecology, host interactions and therapeutic potential”

·Publishing Date: October 14, 2024

·Main conclusion:

A comprehensive review was conducted on the biological characteristics, ecological functions, and interactions of the AKK bacteria with their hosts and diets.

The AKK bacteria have been identified as a model strain that regulates the renewal and health of the intestinal mucus layer.

The potential of AKK bacteria as diagnostic and prognostic biomarkers as well as therapeutic targets has been proposed.

6. Nature Microbiology (2023) – “Genetic mapping of microbial and host traits reveals production of immunomodulatory lipids by Akkermansia muciniphila in the murine gut” (Correction included)

·Publishing Date: February 9, 2023 (Corrected on March 26, 2023)

·Main conclusion:

Through genetic mapping studies, it was discovered that the AKK bacteria produce immunomodulatory lipids in the intestinal tract of mice, which are related to the host's metabolism and immune traits.

These lipids may influence overall health by regulating the immune microenvironment in the gut.

The revised article has updated the author's name format but has not changed the main conclusions.

Summary of Main Scientific Findings

These studies collectively reveal the multiple mechanisms of action of the AKK bacteria:

1. Metabolic Health: The AKK bacteria produce short-chain fatty acids (such as acetic acid and propionic acid) by secreting proteins (such as P9) and metabolizing mucins, thereby improving glucose homeostasis, insulin sensitivity, and lipid metabolism.

2. Immune Regulation: The lipids (such as a15:0-i15:0 PE) of the AKK bacteria and outer membrane proteins regulate the immune response through pathways such as TLR2, maintaining intestinal and systemic homeostasis.

3. Gut Ecology: The AKK bacteria utilize mucin as a nutrient source, enhance the intestinal barrier, compete with other bacterial groups, and influence the host's cholesterol metabolism.

4. Treatment potential: The AKK bacteria and its derivative components (such as P9, lipids) are considered potential intervention targets for metabolic diseases, inflammatory diseases, and cancer immunotherapy.

These articles have established the scientific basis for AKK bacteria as the next generation of probiotics, demonstrating its potential for transformation from basic research to clinical application. It should be noted that some of the conclusions are based on animal models, and more human studies are needed to verify its mechanism and safety in the future.